Enhanced identification of familial hypercholesterolemia using central laboratory algorithms

CONCLUSIONS: The identification of a substantial number of previously undiagnosed and un(der)treated clinical and genetic FH patients within a central laboratory database highlights the feasibility and clinical potential of this targeted screening strategy; both in identifying new FH patients and in improving treatment in this high-risk population.PMID:38643673 | DOI:10.1016/j.atherosclerosis.2024.117548

Source: Atherosclerosis - April 21, 2024 Category: Cardiology Authors: Shirin Ibrahim Nick S Nurmohamed Melchior C Nierman Jim N de Goeij Linda Zuurbier Jeroen van Rooij Willemijn A M Schonck Jard de Vries G Kees Hovingh Laurens F Reeskamp Erik S G Stroes Source Type: research